Members of a multidisciplinary team combining strong scientific backgrounds with specialized communications experience.
Clients across the Biotech and Life Sciences industries.
Countries in Europe and North America where our clients are based.
At Trophic Communications, we deliver strategic, value-building communications and investor relations that resonate with investors, regulators, media, and patient communities. We do this by combining decades of deep biotech sector knowledge, a global industry network, broad scientific insight, and an unwavering commitment to proactive, high-quality service.
Trophic’s public relations program builds visibility and credibility through strategic media engagement, expert-driven content, and thought-leadership, while supporting key milestones such as industry launches, clinical events, and crisis response.
Trophic’s investor relations program is designed to build long-term trust and market visibility through tailored engagement with investors and analysts, strategic communications around earnings and board activity, and targeted support for IPO readiness and global roadshows.
We developed a suite of tailored materials to effectively communicate the client’s message and engage the targeted audience. Deliverables included website content, posters, and social media assets, each designed to maximize reach and impact across channels.
